The abstract is read at the publisher; the summary is JClub's.
Melatonin treatment alleviates collagen- or K/BxN serum-induced arthritis in mice by promoting mitophagy, with Atg5-dependent effects linked to reduced NLRP3 inflammasome activation.
- Why it matters: RA remains difficult to treat, and although melatonin is reported to relieve disease pathology, the mechanism connecting melatonin signaling to inflammatory control is unclear.
- What they did: The study tested melatonin in two established mouse arthritis models and showed it activates MTNR1A to drive mitophagy that clears ROS and leaked mitochondrial DNA, limiting NLRP3 inflammasome signaling and cytokine release; MT’s benefit was largely lost in atg5 fl/fl Lyz2/LysM-cre mice.
- The result: Mitophagy promoted by melatonin is essential for deactivating the NLRP3 inflammasome and alleviating arthritis development, supporting mitophagy as a therapeutic target for RA.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.